Elypta

Select partners: MilliporeSigma.
Primary contact
Nanna Svartz vรคg 4
171 65 Solna
Sweden
+46 (0)8 520 27 885
Nanna Svartz vรคg 4
171 65 Solna
Sweden
+46 (0)8 520 27 885
Links
https://www.elypta.com/
https://www.elypta.com/
Funding ๐ฐ
Total $32.6M
Select investors Bonnier Ventures, Navigare Ventures, Industrifonden, Norrsken VC, Nina Capital, Chalmers Ventures, Hillclimber, Sciety
Key people ๐งโ๐คโ๐ง
- Karl Bergman - CEO
- Francesco Gatto - Co-founder & CSO
- Jens Nielsen - Co-founder
- Volker Liebenberg - CMO
- Johan Vikstrรถm - CFO
- Karin Mattsson - VP R&D
- Fredrik Hรคrenstam - VP BD
Highlights โญ
- Huge market: The cancer diagnostics market is expected to grow to $28.21 billion by 2029, according to Data Bridge Market Research. ๐
- Big impact: Elypta's technology helps spot cancer early, thus increasing the chances of survival. Related, diagnosing cancer before it has the chance to spread too far means that treatment is more likely to be successful.
- Patent-protected tech: Elypta was founded based on 4 patent families that were filed by the company's founders. Their solution, MIRAM, represents the first standardized and commercial kit to profile the human GAGome at a high throughput
- Science-backed: Elypta's founders have published a number of scientific papers and articles on cancer research. The company is also sponsoring a series of clinical studies to evaluate its liquid biopsy across different cancer types.
Video โถ๏ธ
Awards & Recognitions ๐
- 2020 NyTeknik: Top 33 swe startup ๐
- 2020 Nature Research Awards: One to watch ๐
- 2019 Nordic Life Science Award: Winner ๐
- 2019 Genetic Engineering & Biotechnology News: Top 10 under 40 ๐
- 2019 Serendipity Challenge: Nordic start-up of the year ๐
- 2018 MIT Technology Review: Innovators under 35 Europe - EU Pioneer of the year ๐
- 2018 Hello Tomorrow: Among the global top 500 DeepTech start-ups ๐
Last update: August 29, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more